Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,658 | -1,753 | -1,291 | -491 | -2,026 |
| Depreciation Amortization | 2 | 2 | 1 | 1 | 2 |
| Accounts payable and accrued liabilities | 19 | -34 | -51 | -138 | 178 |
| Other Working Capital | 167 | 72 | -24 | -144 | 439 |
| Other Operating Activity | 1,034 | 689 | 653 | 285 | 261 |
| Operating Cash Flow | $-1,436 | $-1,025 | $-711 | $-487 | $-1,145 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 767 | 642 | 415 | 160 | 325 |
| Common Stock Issued | 724 | 475 | 375 | 275 | 776 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -43 |
| Financing Cash Flow | $1,491 | $1,117 | $790 | $435 | $1,058 |
| Exchange Rate Effect | -53 | 40 | -7 | 95 | 23 |
| Beginning Cash Position | 2 | 2 | 2 | 2 | 67 |
| End Cash Position | 4 | 134 | 74 | 46 | 2 |
| Net Cash Flow | $2 | $132 | $71 | $44 | $-65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,436 | -1,025 | -711 | -487 | -1,145 |
| Free Cash Flow | -1,436 | -1,025 | -711 | -487 | -1,145 |